The goal of this clinical trial is to learn about an innovative surgical technique for macular hole repair. This technique is for patients with high myopia using pars plana vitrectomy (PPV) combined with corneal flap transplantation. The main questions it aims to answer are: * Is the innovative surgical technique useful for patients? * Is the surgical technique safe for patients? Participants will: * Undergo PPV combined with corneal flap transplantation to cover the macular hole. * Maintain a prone position for 2 weeks postoperatively. * Be observed by visual acuity, slit lamp, optical coherence tomography (OCT) and fundus photography for 1 year after surgery.
Age range
18 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
best-corrected visual acuity
Timeframe: one month to one year after surgery
complications
Timeframe: one month to one year after surgery
closure of the macular holes
Timeframe: one month to one year after surgery
reattachment of the retina
Timeframe: one month to one year after surgery